Developing an interprofessional team to support patients prescribed long-term high-dose opioid therapy

Despite decreases in US opioid prescribing rates, daily morphine milligram equivalents (MME) prescribed per person remains three times higher than in 1999. An interprofessional team (IPT) was developed to support pain management for patients prescribed long-term high-dose opioids (HDO) in a Federall...

Full description

Saved in:
Bibliographic Details
Published in:Journal of interprofessional care 2023-03, Vol.37 (2), p.320-324
Main Authors: Conley, Michael P, Elmes, Abigail T, Roberts, John R, Buck, Lauren, Fantes, Thomas P
Format: Article
Language:English
Subjects:
Addictions
Adult
Analgesics, Opioid - adverse effects
Behavior modification
Care plans
Chronic Pain - drug therapy
Co-prescribing
Group decision making
Health education
Health facilities
Humans
Interdisciplinary aspects
Interprofessional Relations
Long term
Morphine
Multidisciplinary teams
Naloxone
Narcotics
Nonsteroidal anti-inflammatory drugs
Opioids
Pain
Pain management
Patient education
Patient-centered care
Patients
Practice Patterns, Physicians
Prescribing
Retrospective Studies
Teams
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Despite decreases in US opioid prescribing rates, daily morphine milligram equivalents (MME) prescribed per person remains three times higher than in 1999. An interprofessional team (IPT) was developed to support pain management for patients prescribed long-term high-dose opioids (HDO) in a Federally Qualified Health Center. The IPT utilized a clinical pharmacist, addiction nurse, medical director, and another physician or nurse practitioner to manage adults prescribed long-term HDO, defined as exceeding 50 daily MME. Visits focused on patient education including risks associated with long-term HDO use and effective pain management. The IPT engaged in supportive, individualized care planning for safer, evidence-based pain management, which included, but was not limited to opioid tapers, adjuvant non-opioid pain medications (NOPM), non-pharmacological therapy (NPT), and naloxone co-prescribing. The IPT saw 90% (n = 19) of eligible patients. Excluding outliers, the cohort demonstrated an average 18% ± 24.9 decrease in daily MME. The most common NOPM were acetaminophen, NSAIDs, and pregabalin, and the most common NPT were physical, aquatic, and behavioral therapy. Shared decision-making, collaborative teamwork, and simple patient-centered goals are key to moving patients toward safer, evidence-based therapy.
ISSN:1356-1820
1469-9567
DOI:10.1080/13561820.2022.2061929